Rocco, S.; Maglione, A.; Schiavo, V.; Ferrando, A.; Fava, C.; Cilloni, D.; Pergolizzi, B.; Panuzzo, C.
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells. J. Clin. Med. 2025, 14, 392.
https://doi.org/10.3390/jcm14020392
AMA Style
Rocco S, Maglione A, Schiavo V, Ferrando A, Fava C, Cilloni D, Pergolizzi B, Panuzzo C.
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells. Journal of Clinical Medicine. 2025; 14(2):392.
https://doi.org/10.3390/jcm14020392
Chicago/Turabian Style
Rocco, Simone, Alessandro Maglione, Valentina Schiavo, Alessandro Ferrando, Carmen Fava, Daniela Cilloni, Barbara Pergolizzi, and Cristina Panuzzo.
2025. "Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells" Journal of Clinical Medicine 14, no. 2: 392.
https://doi.org/10.3390/jcm14020392
APA Style
Rocco, S., Maglione, A., Schiavo, V., Ferrando, A., Fava, C., Cilloni, D., Pergolizzi, B., & Panuzzo, C.
(2025). Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells. Journal of Clinical Medicine, 14(2), 392.
https://doi.org/10.3390/jcm14020392
